The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, the severity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, therapeutic digital and artificial intelligence. In the past three years alone, more than 633,000 patents have been filed and granted in the pharmaceutical industry, according to GlobalData’s report Robotics in Pharmaceuticals: Microneedles for Transdermal Drug Delivery.
However, not all innovations are equal and do not follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that mirrors their typical life cycle, from early emergence to accelerated adoption before finally leveling off and reaching maturity.
Identifying where a particular innovation is on this journey, especially those in the emerging and accelerating phases, is critical to understanding their current level of adoption and the likely future trajectory and impact that ‘they will have.
100 innovations will shape pharmaceutical industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models based on more than 756,000 patents, there are 110 areas of innovation that will shape the future of the industry. ‘industry.
Within the emerging the innovation phase, programmable temperature control, automation of microreactors and automated laboratory analyzers are disruptive technologies that are in the early stages of application and need to be closely monitored. Microneedles for transdermal drug delivery, tissue culture automation and programmable sterilization are among the accelerating areas of innovation, where adoption has steadily increased.
S-curve of innovation for robotics in the pharmaceutical industry
Microneedles for transdermal drug delivery is a key area of innovation in robotics
Microneedles are new, micron-sized, sterilized, minimally invasive drug delivery needles used to deliver therapeutic agents. In addition to transdermal drug delivery applications, its use has expanded to intraocular, cardiovascular, gastrointestinal, intracochlear, lymphatic, and vaginal drug delivery.
GlobalData’s analysis also reveals which companies are at the forefront of each area of innovation and assesses the potential reach and impact of their patenting activity in different applications and geographies. According to GlobalData, more than 100 companies, spanning technology providers, established pharmaceutical companies and emerging start-ups, are engaged in the development and application of microneedles for transdermal drug delivery.
The key players in microneedles for transdermal drug delivery – a breakthrough innovation in the pharmaceutical industry
“Application diversity” measures the number of different applications identified for each relevant patent and broadly divides companies into “niche” or “diversified” innovators.
“Geographical scope” refers to the number of different countries in which each relevant patent is registered and reflects the scope of intended geographical application, ranging from “global” to “local”.
Sorrento Therapeutics is the leading patent filer in microneedle drug delivery, followed by Hisamitsu Pharmaceutical and Kimberly-Clark. Sorrento Therapeutics recently acquired Sofusa, a lymphatic microneedle delivery platform, from Kimberly-Clark. The company also recently entered into a licensing agreement with the Mayo Clinic for a Phase 1b pilot study using the Sofusa lymphatic microneedle to deliver ipilimumab to melanoma patients.
In terms of application diversity, Broadcom is the leading company, followed by Endoderma and PCI Biotech. Thanks to its geographic reach, Radius Health ranks first. Grifols and Ichor Medical Systems occupy the second and third positions respectively.
To better understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest Pharmaceutical Topic Research Report.
#Robotic #innovation #leading #companies #field #microneedles #transdermal #drug #delivery